These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3021345)

  • 1. Establishment of mutant murine mammary carcinoma FM3A cell strains transformed with the herpes simplex virus type 2 thymidine kinase gene.
    Shimizu K; Ren L; Ayusawa D; Seno T; Balzarini J; De Clercq E
    Cell Struct Funct; 1986 Sep; 11(3):295-301. PubMed ID: 3021345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
    Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of mutant FM3A murine mammary carcinoma cell strains transformed with the herpes simplex virus type 1 thymidine kinase gene.
    Ayusawa D; Shimizu K; Seno T; Balzarini J; De Clercq E
    Jpn J Cancer Res; 1985 Oct; 76(10):984-8. PubMed ID: 3001011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine mammary FM3A carcinoma cells transformed with the herpes simplex virus type 1 thymidine kinase gene are highly sensitive to the growth-inhibitory properties of (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; de Clercq E; Ayusawa D; Seno T
    FEBS Lett; 1985 Jun; 185(1):95-100. PubMed ID: 2987041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
    Balzarini J; Bohman C; De Clercq E
    J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T
    Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel (E)-5-(2-iodovinyl)-2'-deoxyuridine derivatives as potential cytostatic agents against herpes simplex virus thymidine kinase gene transfected tumors.
    Balzarini J; Morin KW; Knaus EE; Wiebe LI; De Clercq E
    Gene Ther; 1995 Jul; 2(5):317-22. PubMed ID: 7671107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.
    Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased sensitivity of thymidine kinase-deficient (TK-) tumor cell lines to the cell growth inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds.
    Balzarini J; De Clercq E; Verbruggen A; Crumpacker C; Ayusawa D; Seno T
    Anticancer Res; 1986; 6(5):1077-84. PubMed ID: 2432829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
    Panet A; Falk H
    J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus thymidine kinase activity of thymidine kinase-deficient Escherichia coli K-12 mutant transformed by hybrid plasmids.
    Kit S; Otsuka H; Qavi H; Hazen M
    Proc Natl Acad Sci U S A; 1981 Jan; 78(1):582-6. PubMed ID: 6264449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence and characterization of acyclovir-resistant herpes simplex virus isolates: report on a two-year sensitivity screening survey.
    Nugier F; Colin JN; Aymard M; Langlois M
    J Med Virol; 1992 Jan; 36(1):1-12. PubMed ID: 1315366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of a neurovirulent herpes simplex virus type 2 strain with reduced thymidine kinase activity.
    Tanaka S; Toh Y; Mori R
    Arch Virol; 1993; 131(1-2):61-73. PubMed ID: 8392322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary characterization of a mutant of herpes simplex virus type 1 selected for acycloguanosine resistance in vitro.
    Palú G; Summers WP; Valisena S; Tognon M
    J Med Virol; 1988 Mar; 24(3):251-62. PubMed ID: 2835423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly reliable heterologous system for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues.
    Bestman-Smith J; Schmit I; Papadopoulou B; Boivin G
    J Virol; 2001 Apr; 75(7):3105-10. PubMed ID: 11238837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.